Ireland - English - HPRA (Health Products Regulatory Authority)

curium netherlands b.v. - sodium pyrophosphate decahydrate - kit for radiopharmaceutical preparation - 20 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) stannous agent labelled cells

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

curium belgium s.p.r.l.-b.v.b.a. - sodium pyrophosphate 20 mg - kit for radiopharmaceutical preparation - 20 mg - sodium pyrophosphate decahydrate 20 mg - technetium (99mtc) stannous agent labelled cells

Singapore - English - HSA (Health Sciences Authority)

qt instruments (s) pte ltd - sodium pyrophosphate decahydrate - injection, powder, for solution - sodium pyrophosphate decahydrate 20mg/vial

United States - English - NLM (National Library of Medicine)

curium us llc - sodium pyrophosphate (unii: o352864b8z) (pyrophosphoric acid - unii:4e862e7grq), stannous chloride (unii: 1bqv3749l5) (stannous cation - unii:qi30938bms) - sodium pyrophosphate 11.9 mg in 10 ml - technetium tc 99m pyrophosphate injection is a skeletal imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction. as an adjunct in the diagnosis of confirmed myocardial infarction (ecg and serum enzymes positive), the incidence of false negative images has been found to be 6%. false negative images can also occur if made too early in the evolutionary phase of the infarct or too late in the resolution phase. in a limited study involving 22 patients in whom the ecg was positive and serum enzymes questionable or negative, but in whom the final diagnosis of acute myocardial infarction was made, the incidence of false negative images was 23%. the incidence of false positive images has been found to be 7 to 9%. false positive images have been reported following coronary by-pass graft surgery, in unstable angina pectoris, old myocardial infarcts and in cardiac contusions. technescan pyp is a blood pool imaging agen

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

curium pharma uk ltd - sodium pyrophosphate decahydrate - kit for radiopharmaceutical preparation - 20mg

Australia - English - Department of Health (Therapeutic Goods Administration)

mallinckrodt australia pty ltd - sodium pyrophosphate -

Australia - English - Department of Health (Therapeutic Goods Administration)

landauer radiopharmaceuticals pty ltd - sodium pyrophosphate, quantity: 11.9 mg - injection, powder for - excipient ingredients: stannous chloride dihydrate; water for injections - indications as at 1 february 2005: technetium tc 99m pyrophosphate injection is a skeletal imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction. as an adjunct in the diagnosis of confirmed myocardial infarction (ecg and serum enzymes positive), the incidence of false negative images has been found to be 6 percent. false negative images can also occur if made too early in the evolutionary phase of the infarct or too late in the resolution phase. in a limited study involving 22 patients in whom the ecg was positive and serum enzymes questionable or negative, but in whom the final diagnosis of acute myocardial infarction was made, the incidence of false negative images was 23 percent. the incidence of false positive images has been found to be 7 to 9 percent. false positive images have been reported following coronary by-pass graft surgery, in unstable angina pectoris, in old myocardial infarcts, and in car

Malta - English - Medicines Authority

curium netherlands b.v westerduinweg 3, 1755 le petten, netherlands - sodium pyrophosphate, decahydrate - kit for radiopharmaceutical preparation - sodium pyrophosphate decahydrate 20 mg - diagnostic radiopharmaceuticals

United States - English - NLM (National Library of Medicine)

curium us llc - oxidronate disodium (unii: h852yk87wp) (oxidronic acid - unii:71mr4v32ti) - oxidronate disodium 3.15 mg - technescan hdp tc 99m is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients. none known. all procedures should be conducted using waterproof gloves. use shielded syringe during transport and administration of tc 99m solutions. - remove plastic disc from technescan hdp vial and cleanse top by swabbing with alcohol. note: if dose is for a single adult patient or for a pediatric patient, see unit dose preparation method below. - place vial in lead vial shield. add 3 to 6 ml of sodium pertechnetate tc 99m solution and secure with a fitted lead cover. in choosing the amount of tc 99m radioactivity to be used, the number of doses desired, the activity of each dose [recommended adult dose is 555 mbq (15 mci) with a range of 370 to 740 mbq (10 to 20 mci)] and radioactive decay must be taken into account. the recommended maximum amount of tc 99m radioactivity to be added to the vial is 11.1 gigabecquerels (300 mci). note: the contents of the vial are